Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2012
05/08/2012CA2459224C 1,3-benzothiazinone derivatives and the use thereof
05/08/2012CA2368184C Method and means for treating post-polio syndrome
05/08/2012CA2353574C Analogues of glp-1
05/08/2012CA2266859C Colostrinin, and uses thereof
05/08/2012CA2229741C Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
05/03/2012WO2012058545A2 Process for analyzing and establishing dosage size in an ingestible film
05/03/2012WO2012058219A2 Deuterium enriched rasagiline
05/03/2012WO2012058211A2 Quinazoline derivatives, compositions, and uses related thereto
05/03/2012WO2012057312A1 Tau imaging probe
05/03/2012WO2012057300A1 Novel pyridine derivative
05/03/2012WO2012057248A1 Naphthyridine derivative
05/03/2012WO2012057247A1 Fused aminodihydropyrimidine derivative
05/03/2012WO2012056246A1 Combination treatment of major depressive disorder
05/03/2012WO2012056229A1 Inflammatory disease
05/03/2012WO2012056157A1 Peptide compound useful for inhibiting amyloid plaque formation
05/03/2012WO2012056048A1 Treatment of inflammation
05/03/2012WO2012055981A1 Immunogenic compositions and methods for treating neurologic disorders
05/03/2012WO2012055945A1 Indole derivatives and process for their preparation
05/03/2012WO2012055942A1 Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive impairment or alzheimer's disease
05/03/2012WO2012055888A1 Diaza-spiro[5.5]undecanes useful as orexin receptor antagonists
05/03/2012WO2012055826A1 TREATMENT OF MeCP2-ASSOCIATED DISORDERS
05/03/2012WO2012055018A1 Therapeutic compositions for diabetic symmetrical polyneuropathy
05/03/2012WO2012054988A1 Seleno-compounds and therapeutic uses thereof
05/03/2012WO2012017324A3 Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
05/03/2012WO2012011731A3 Method for separating and identifying calgranulin a as a dementia marker from blood cells
05/03/2012WO2011162480A3 Composition for treating prion diseases comprising hif-1α agonist
05/03/2012WO2011159124A3 Novel benzoxazole derivative having inhibitory activity against interleukin-6, preparation method thereof, and pharmaceutical composition containing same
05/03/2012WO2011155797A3 Hemioxalate salt of crystalline o-desmethylvenlafaxine, preparation method thereof, and pharmaceutical composition thereof
05/03/2012WO2011122879A3 Composition comprising coumestrol or a bean extract containing coumestrol
05/03/2012US20120108669 Method of treating sleep disorders using eplivanserin
05/03/2012US20120108662 Compositions and methods for treating skin disorders
05/03/2012US20120108654 Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa
05/03/2012US20120108650 Micro rna markers and methods related thereto
05/03/2012US20120108643 Method of increasing the extent of absorption of tizanidine
05/03/2012US20120108640 Methods and compositions for the treatment of neuropsychiatric disorders
05/03/2012US20120108637 Fused Bicyclic-Substituted Amines as Histamine-3 Receptor Ligands
05/03/2012US20120108636 Allosteric Enhancers of th A1 Adenosine Receptor
05/03/2012US20120108629 New use of neferine
05/03/2012US20120108627 Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation
05/03/2012US20120108625 Novel forms of tiotropium bromide and processes for preparation thereof
05/03/2012US20120108624 Treatment of dyskinesia related disorders
05/03/2012US20120108622 Pharmaceutical formulation containing gelling agent
05/03/2012US20120108621 Pharmaceutical preparation containing oxycodone and naloxone
05/03/2012US20120108618 Thia-triaza-indacenes
05/03/2012US20120108617 Methods and compositions involving (s)-bucindolol
05/03/2012US20120108616 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
05/03/2012US20120108614 Compounds and compositions for treating chemical warfare agent-induced injuries
05/03/2012US20120108613 Compounds and compositions for treating chemical warfare agent-induced injuries
05/03/2012US20120108611 5, 6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
05/03/2012US20120108609 Dihydrooxazol-2-amine derivatives
05/03/2012US20120108607 Optically active 3-[(phenylpiperazin-1-yl)alkyl]-3- alkyl-oxindole derivatives having cns activity
05/03/2012US20120108605 O-glcnac transferase inhibitors and uses thereof
05/03/2012US20120108603 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
05/03/2012US20120108599 Methods and compositions for the treatment of metabolic disorders
05/03/2012US20120108597 Azaquinazolinediones Chymase Inhibitors
05/03/2012US20120108596 Aza-Bicyclic Amine N-Oxide Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligand Pro-Drugs
05/03/2012US20120108588 Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h, 4h,6h) carbaldehyde derivatives
05/03/2012US20120108587 Aza- and Diaza-Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof
05/03/2012US20120108584 2h or 3h-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
05/03/2012US20120108583 Tricyclic Compounds As mPGES-1 Inhibitors
05/03/2012US20120108575 Heterocyclic-substituted piperidine compounds and the uses thereof
05/03/2012US20120108573 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
05/03/2012US20120108568 SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS
05/03/2012US20120108566 Nicotinamides as jak kinase modulators
05/03/2012US20120108550 Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments
05/03/2012US20120108549 Neuroprotective compounds and their use
05/03/2012US20120108548 Molecular tweezers for the treatment of amyloid-related diseases
05/03/2012US20120108545 Trioxane Monomers and Dimers
05/03/2012US20120108534 Dihydrothienopyrimidines for the treatment of inflammatory Diseases
05/03/2012US20120108532 Pharmaceutical composition for neuroprotective treatment in patients with ictus comprising citicoline and uric acid
05/03/2012US20120108528 New therapeutic approaches for treating neuroinflammatory conditions
05/03/2012US20120108518 Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
05/03/2012US20120108510 Methods of improving behavioral therapies
05/03/2012US20120108507 Methods for In Vivo Cell Reprogramming
05/03/2012US20120108505 Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
05/03/2012US20120107846 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
05/03/2012US20120107833 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
05/03/2012US20120107432 Composition of extract of emblica officinalis and method of preparing the same
05/03/2012US20120107411 Treatment of stress
05/03/2012US20120107406 Dry Powder Formulations
05/03/2012US20120107402 Process for analyzing and establishing dosage size in an ingestible film
05/03/2012US20120107396 Compositions For The Treatment of Central Nervous System Disorders Including Depression Employing Novel Drug Combination Therapy To Reduce Suicidality In Patients
05/03/2012US20120107392 Use of huperzine for disorders
05/03/2012US20120107334 Method for enhancing immune response with peptide
05/03/2012US20120107328 Gamma secretase modulators
05/03/2012US20120107321 Antibodies And Epitopes Specific To Misfolded Prion Protein
05/03/2012US20120107310 Methods of antagonizing signal transduction in spinal cord cells
05/03/2012US20120107298 Use of LCAT for Treating Anemia and Red Blood Cell Dysfunction
05/03/2012US20120107290 Non-replicating micro-organisms and their immune boosting effect
05/03/2012US20120107284 Stem cells for transplantation and methods for production thereof
05/03/2012US20120107281 Compositions and methods for modifying cell surface glycans
05/03/2012US20120107277 Use of the combination of teriflunomide and interferon beta for treating multiple sclerosis
05/03/2012US20120107272 Synthetic methods and derivatives of triphosphate oligonucleotides
05/03/2012US20120107269 Thiophene derivatives
05/03/2012US20120107252 Method for forming cyclodextrin polymer and lipophilic compound emulsions, resulting emulsions, and compositions including said emulsions
05/03/2012US20120107250 Abuse-proofed dosage form
05/03/2012US20120107243 Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier
05/03/2012CA2816285A1 Naphthyridine derivative
05/03/2012CA2816104A1 Deuterium enriched rasagiline
05/03/2012CA2816022A1 Quinazoline derivatives, compositions, and uses related thereto
1 ... 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 ... 1833